Usefulness of Pulmonary Artery Pulsatility Index in Predicting Acute Kidney Injury Following Continuous-Flow Left Ventricular Assist Device Implantation in Ambulatory Advanced Heart Failure Patients
Nützlichkeit des Pulmonary Artery Pulsatility Index zur Vorhersage einer akuten Nierenschädigung nach Implantation eines kontinuierlich fließenden linksventrikulären Assist-Devices bei ambulanten Patient:innen mit fortgeschrittener Herzinsuffizienz
Journal of Clinical Medicine · 08.11.2026 · 15 (21) · 8721
DOI: 10.3390/jcm15218721 ↗Auf einen Blick
Bei 121 ambulanten Patient:innen mit fortgeschrittener Herzinsuffizienz war ein präoperativer PAPi <2,1 mit einem höheren Risiko für postoperatives AKI assoziiert. Die Trennschärfe war jedoch nur mäßig.
Fragestellung
Sagt der präoperative Pulmonary Artery Pulsatility Index (PAPi) eine postoperative akute Nierenschädigung nach CF-LVAD-Implantation voraus?
Methode
Retrospektive Analyse von 121 stabilen ambulanten Patient:innen mit fortgeschrittener Herzinsuffizienz (INTERMACS 4–6) nach CF-LVAD-Implantation von 2020 bis 2024; AKI nach RIFLE-Kriterien in den ersten 2 postoperativen Tagen.
Ergebnisse
AKI trat bei 43 Patient:innen (35,5 %) auf. PAPi war in der AKI-Gruppe niedriger (1,4 ± 0,4 vs. 3,2 ± 1,2; p = 0,001). AUC 0,62 (95 %-KI 0,52–0,73); Cut-off 2,1: Sensitivität 0,82, Spezifität 0,42.
Einschränkungen
Retrospektive Einzelkohortenanalyse; AUC nur mäßig; die Autor:innen nennen eine mögliche Abhängigkeit von Venestauungs-Metriken wie RAP.
Schlussfolgerung der Autor:innen
Ein präoperativer PAPi <2,1 war mit einem höheren AKI-Risiko assoziiert. Die Befunde werden von den Autor:innen als explorativ und hypothesengenerierend bewertet.
Kernaussagen
- AKI bei 43 von 121 Patient:innen
- Niedrigerer PAPi bei AKI (1,4 ± 0,4 vs. 3,2 ± 1,2)
- AUC 0,62; Cut-off 2,1 mit Sensitivität 0,82
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 08.11.2026. Verfasst von Cem Doğan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Kartal Kosuyolu Training and Research Hospital, Kartal, Istanbul 34865, Türkiye. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Acute kidney injury (AKI) is a frequent and serious complication after the implantation of continuous-flow left ventricular assist devices (CF-LVADs), often mediated by right ventricular (RV) dysfunction, systemic venous congestion, and subsequent suboptimal device filling. The pulmonary artery pulsatility index (PAPi) is a hemodynamic parameter reflecting RV function. This study evaluated the predictive value of preoperative PAPi for postoperative AKI in ambulatory advanced heart failure patients.
Methods
A total of 121 stable, ambulatory advanced heart failure patients (INTERMACS profiles 4–6) who underwent CF-LVAD implantation between 2020 and 2024 were retrospectively analyzed. Preoperative demographic, clinical, and invasive hemodynamic parameters were collected. Postoperative AKI was defined using serum creatinine criteria according to the RIFLE consensus during the first two postoperative days.
Results
Postoperative AKI developed in 43 patients (35.5%). The mean PAPi value was significantly lower in the AKI group compared with the non-AKI group (1.4 ± 0.4 vs. 3.2 ± 1.2, p = 0.001). Preoperative right atrial pressure (RAP) was significantly higher in patients who developed AKI. Receiver operating characteristic (ROC) curve analysis demonstrated modest discrimination, with an area under the curve (AUC) of 0.62 (95% CI: 0.52–0.73). A PAPi cut-off value of 2.1 yielded a sensitivity of 0.82 and a specificity of 0.42.
Conclusions
In ambulatory advanced heart failure patients undergoing CF-LVAD implantation, a preoperative PAPi value below 2.1 shows an association with a higher risk of postoperative AKI. However, given its modest independent discriminative capacity (AUC 0.62) and potential dependence on venous congestion metrics like RAP, these preliminary findings should be considered exploratory and hypothesis-generating, warranting further external validation in broader cohorts.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Kartal Kosuyolu Training and Research Hospital, Kartal, Istanbul 34865, Türkiye.
- Department of Cardiovascular Surgery, Kartal Kosuyolu Training and Research Hospital, Kartal, Istanbul 34865, Türkiye.
- Department of Cardiology, School of Medicine, Yalova University, Yalova 77200, Türkiye.
ORCID-Profile: Cem Doğan, Gülümser Sevgin Halil, Sabit Sarıkaya, Cemalettin Yılmaz, Rezzan Deniz Acar
Zitieren
APA
Doğan, C., Efe, S. Ç., Halil, G. S., Akbal, Ö. Y., Karagöz, A., Sarıkaya, S., Yılmaz, C., Zehir, R., Acar, R. D., & Kırali, M. K. (2026). Usefulness of Pulmonary Artery Pulsatility Index in Predicting Acute Kidney Injury Following Continuous-Flow Left Ventricular Assist Device Implantation in Ambulatory Advanced Heart Failure Patients. Journal of Clinical Medicine, 15(21), 8721. https://doi.org/10.3390/jcm15218721
Vancouver
Doğan C, Efe SÇ, Halil GS, Akbal ÖY, Karagöz A, Sarıkaya S, et al. Usefulness of Pulmonary Artery Pulsatility Index in Predicting Acute Kidney Injury Following Continuous-Flow Left Ventricular Assist Device Implantation in Ambulatory Advanced Heart Failure Patients. Journal of Clinical Medicine. 2026;15(21):8721. doi:10.3390/jcm15218721
BibTeX
@article{Doan2026,
author = {Doğan, Cem and Efe, Süleyman Çağan and Halil, Gülümser Sevgin and Akbal, Özgür Yaşar and Karagöz, Ali and Sarıkaya, Sabit and Yılmaz, Cemalettin and Zehir, Regayip and Acar, Rezzan Deniz and Kırali, Mehmet Kaan},
title = {Usefulness of Pulmonary Artery Pulsatility Index in Predicting Acute Kidney Injury Following Continuous-Flow Left Ventricular Assist Device Implantation in Ambulatory Advanced Heart Failure Patients},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {21},
pages = {8721},
doi = {10.3390/jcm15218721}
}
EUVIMED